Additional Information for Carbidopa And Levodopa Tablets
Carbidopa and Levodopa tablets are a medication used to treat symptoms of Parkinson's disease. They belong to the supply class Drugs and Biologicals in the supply group Medical, Dental, and Veterinary Equipment and Supplies.
Carbidopa and Levodopa are combined in a tablet form to help manage the symptoms of Parkinson's disease, such as tremors, stiffness, and difficulty with movement. Levodopa is converted into dopamine in the brain, which helps to improve motor function. Carbidopa is added to the medication to enhance the effectiveness of Levodopa and reduce certain side effects.
These tablets are typically prescribed by a healthcare professional and should be taken as directed. It is important to follow the prescribed dosage and frequency to achieve the best results. Common side effects may include nausea, dizziness, and drowsiness.
It is important to consult with a healthcare professional for more information about Carbidopa and Levodopa tablets, including potential side effects, drug interactions, and any specific instructions for use.
Related Item Names for INC 35474 Carbidopa And Levodopa Tablets
NATO Stock Numbers with Item Name 35474 Carbidopa And Levodopa Tablets Page 1 of 1
- NDC00228-2539-10
- RNCC: 3 | RNVC: 2 | DAC: 4
- SINEMET-25/250
- RNCC: 5 | RNVC: 1 | DAC: 4
- NDC00228-2540-10
- RNCC: 5 | RNVC: 2 | DAC: 4
- 7896112456940
- RNCC: 3 | RNVC: 2 | DAC: U
- 5694
- RNCC: 3 | RNVC: 2 | DAC: 4
- SINEMET-25/100
- RNCC: 5 | RNVC: 1 | DAC: 6
- NDC00006-0647-68
- RNCC: 5 | RNVC: 9 | DAC: 4
- NDC00056-0647-28
- RNCC: 3 | RNVC: 2 | DAC: 4
- 8470008241774
- RNCC: 5 | RNVC: 2 | DAC: U
- 8470009537944
- RNCC: 5 | RNVC: 2 | DAC: U